seed
Stage
1
Investors
About
MPC Therapeutics develops metabolic reprogramming solutions using small molecules to enhance the durability, consistency, and effectiveness of cell therapies, particularly improving CAR-T therapy performance.
Explore MPC Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.